Shoulder Innovations, Inc. (SI) stock

SINYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3052% above fair value

$20.69−0.39 (-1.85%)

Close on Nov 13, 2026Market cap $430.74MP/E –Yield –

Shoulder Innovations enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Shoulder Innovations's enterprise value was $372.25M on Nov 11, 2026, against $195.39M a year earlier.

Period	Period end	Value	Change
2026	Nov 11, 2026	$372.25M	+116.5%
2025	Dec 31, 2025	$171.92M	–

Parsed from the XBRL in Shoulder Innovations's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is SI.

Revenue growth54.9% · median 15.3%

Gross margin77.8% · median 67.2%

Operating margin-54.4% · median -16.2%

Net margin-51.7% · median -23.7%

Advertisement
300 × 250

See a number that looks wrong?